LENZ Therapeutics (LENZ) Short Interest
Nasdaq • LENZ • US52635N1037
As of Oct 27, 2026, ORTEX estimated 40.9% of free float sold short, 12.5 days to cover, cost to borrow 1.4%. Sign up for live short interest data.
Nasdaq • LENZ • US52635N1037
As of Oct 27, 2026, ORTEX estimated 40.9% of free float sold short, 12.5 days to cover, cost to borrow 1.4%. Sign up for live short interest data.
This page tracks how heavily LENZ Therapeutics (Nasdaq:LENZ) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
LENZ Therapeutics (Nasdaq: LENZ) has a market capitalization of $128.67M. Last close $4.11 (as of 2026-11-12); 52-week range $2.80 to $32.13. ORTEX data as of 2026-10-27: short interest was 40.93% of free float, 12.5 days to cover and the average cost to borrow was 1.4%. Sign up for live short interest data.